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Dr Charles B. Huddleston (St Louis, Mo). Thanks very much
for providing me the manuscript and the slides and illustrations. It
is an excellent presentation and analysis of the data.
We have looked at the same issue in only our infant population.
We selected that infant population only because that would be
a more consistent group and one in which the growth would be
more obvious in terms of what the expectations would be. I think
that you would not necessarily have to analyze the data specifically
when you see a teenager come back for the 15-year follow-up after
having had a transplant as an infant, for the heart must be growing.
However, this study was a very nice objective demonstration of
that.
Using ventricular dimensions is perhaps the most obvious way
to assess the growth of a heart, but there are a number of variables
that could play into the ventricular dimensions—resting heart rate,
episodes of rejection, the presence of hypertension. I wonder
whether using valvular dimensions, such as the mitral and aortic
valve annular diameters, to assess the growth might actually be
a more accurate way to figure this out. Do you have any comments
about that?
Dr Delmo Walter. Thank you very much for your very con-
structive critique. That is certainly an excellent suggestion. We
will look into all cases in which we have sufficiently complete
echo data on mitral valve measurements of those children, which
I am sure we have.
However, in this present study we did not concern ourselves
with the mitral valve or the annular sizes to measure ventricular
growth, although you have a point there. We were more interested
in the growth of the myocardium inasmuch as this is the structure
that is mostly affected in transplantation, especially in cases of re-
jection and immunosuppression. In addition, looking at the mitral
valve annulus as an indicator of ventricular growth is a rational
idea. If we look at these dimensions in the context of an unbal-
anced atrioventricular canal, this is valid and reliable. Perhaps176 The Journal of Thoracic and Cardiovascular Surgwe could apply this dimension in transplanted hearts. But I may
be able to take a look at your suggestion.
Dr Huddleston. Have you actually ever encountered a single
patient in whom you were suspicious that the growth had been in-
adequate, such as someone who is presenting late with restrictive
type of physiology on their follow-up cardiac catheterizations?
Dr Delmo Walter. I cannot recall any particular case in which
we have a restrictive physiology. I am not aware of such where we
had to discuss a heart that did not grow sufficiently, or even under-
went a retransplantation for that reason. In further studies, we will
begin to look into those cases that lie at the borderline margins of
the spectrum, like slow-growing or fast-growing hearts, and see
whether there could be significant specific findings connected
with those. I think this is a special point to consider in the study
of growth of transplanted hearts. What I can recall, Dr Huddleston,
is that we have 5 patients who were 3 standard deviations below
normal at early follow-up but were close to normal range at late
follow-up. This included 3 infants who have shown delayed linear
growth while still receiving steroids and 2 children receiving high-
dose immunosuppressants because of rejection episodes. In these
patients with poor linear growth, cardiac chamber growth occurred
appropriate for BSA.
Dr Huddleston. Finally, there is this dogma, at least in the pe-
diatric heart transplantation field, about taking small hearts, and to
avoid that particularly in the presence of borderline pulmonary hy-
pertension. I am not convinced that that is true, and I wondered
whether you have any thoughts about taking small donors for
some of your patients in light of the existing dogma.
Dr Delmo Walter. Thank you again for pointing out this
dogma. The dogma lies on the inability of a smaller heart to over-
come the pulmonary vascular resistance. It is known that the neo-
natal heart has impaired ability to increase stroke volume in
response to an increased preload, and such an increase would be
essential to provide adequate circulation for a larger recipient.
There are several reports to increase or extend the donor criteria
so that the donor organ is available for anybody who needs it, like
transplanting even small hearts whether the donor/recipient BSA
ratio is more than 1.2 or discrepant. Patients who receive heart
transplants from smaller donors rely on increased heart rate and el-
evated filling pressures to maintain appropriate cardiac output.
Thus, the smaller donor heart has the ability to maintain circulation
in a larger recipient using the maximum reserve over a substantial
period of time and also has the capability to undergo hypertrophy
despite immunosuppression. My senior author, Professor Hetzer,
has reported on 30 patients who received hearts from smaller do-
nors whose weight was up to 32% less than the recipient’s weight.
Of these, 13 patients had a weight difference between 5% and
10%, 10 had a difference between 10% and 20%, 3 had a difference
between 21% and 30%, and 4 had a difference of more than 30%. It
was concluded in this report that the postoperative graft function
was acceptable for those recipients whose body weight did not ex-
ceed the donor’s weight by more than 20%. However, a weight
difference of more than 20% was associated with significant post-
operative graft dysfunction, although only 1 patient had amarkedly
elevated pulmonary vascular resistance. At the outset, the recipient
should not have severe pulmonary hypertension or significantly el-
evated pulmonary vascular resistance, the graft should be healthy,
and the ischemic time should be relatively short, at least less thanery c January 2012
Delmo Walter et al Cardiothoracic Transplantation4 hours. Of course, it is ideal to use the heart from a donor with
an exact donor/recipient BSA ratio match. However, given the
donor shortage, this is probably not achievable. Our data support
the premise that in selected circumstances, smaller hearts do
not adversely affect the early mortality or late outcome. We
believe that it is safe to extend thewidely accepted donor–recipient
weight match criterion to less than 20%. Nowadays, with clear-cut
indication of transplantation, refinement in donor management,
improvements in perioperative management, and improved immu-
nosuppression, this dogma should therefore be nonexistent. I
would like to say that this area of pediatric transplantation is
a minefield when we talk about outcome of size mismatch on
hemodynamics and growth. There are a lot of interesting areas
of research we can really embark on to improve our understanding
of pediatric heart transplantation.
Dr Ali Mumtaz (Norfolk, Va). Can you share with us any par-
ticular technical problems in trying to fit a very large heart into
a very small chest? I noted in your protocol you said that you
would accept a heart 4 times the size. I personally have had expe-
rience only up to a third. Even at that, at 3 times, in a 2-year-old
child, I had to leave the chest open to wait for the swelling from
previous congestive heart failure to go down and then close the
chest. I am curious to see what measures you take to fit the heart
4 times the normal size.
Dr Delmo Walter. We apply the simple technique already
known to all of us. We open both the pleura. When we cannotThe Journal of Thoracic and Caclose the chest, we leave it open until the swelling decreases
and then perform a delayed closure, although this is an instance
we particularly avoid in transplantation. There were 2 or 3 cases
in which we had to open the central fibrous body of the dia-
phragm and allow the heart to hang in the abdominal cavity for
a time. Inasmuch as most of our patients were bridged to trans-
plant with a mechanical circulatory assist device, their hearts
were at the outset enlarged, and therefore their chest cavity as
well, although their body weight or BSAwas much less than their
chest diameter. I would like to clarify a point I have mentioned in
my presentation as well: When I said that it is our institutional
policy to implant a donor heart 4 times larger than the recipient,
I was not talking about the size of the heart; rather, I meant that
the donor weight or BSA is maybe 4 times that of the recipient’s
weight or BSA.
Dr Emile A. Bacha (New York, NY). Can I clarify something?
The heart is 4 times the size or the donor is 4 times the
size? Also, are we talking BSA or weight? When you say 4
times the size, do you mean the donor heart you accept is up
to 4 times the size, dimension, or do you accept 4 times BSA
or 4 times weight?
Dr Delmo Walter. Four times the BSA, not 4 times the size of
the recipient’s heart itself, because that is not possible. The donor
may be 4 times the BSA or weight of the recipient.
Dr Bacha. Right. That is why I am clarifying. Thank you very
much.rdiovascular Surgery c Volume 143, Number 1 177
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